Trump signs executive order to expedite FDA review of psychedelic drugs for medical treatments
President Trump signed an executive order directing the FDA to speed up reviews of certain psychedelic drugs, including ibogaine, for treating conditions like PTSD and depression. The signing ceremony included Joe Rogan, Health Secretary RFK Jr., and former Navy SEAL Marcus Luttrell. The FDA will issue priority vouchers for three psychedelics and take steps to enable the first U.S. human trials of ibogaine.
24
Divergence score
This event sits in the top 23% of divergence this week. 12 outlets covered it, splitting into 10 framing camps across 4 bias groups.
10 camps
4 bias groups
The spectrum · how 10 outlets placed this story
LeftCenterRight
Reuters
Washington Post
Washington Examiner
AP News
Al Jazeera
NY Post
The Hill
CNN
PBS NewsHour
New York Times
Supportive of action
Neutral
Dismissive
Critical
Alarmist
International angle
The split, in one line
Coverage emphasizes either breakthro...
How each outlet covered it
Trump set to ease restrictions on psychedelic drug used to treat PTSD - Reuters
Trump plans to ease access to psychedelics like psilocybin, ibogaine - The Washington Post
Trump signs order boosting psychedelic drugs for PTSD with Rogan looking on
Trump signs order to speed review of psychedelics, including the controversial drug ibogaine
Trump joined by Joe Rogan as he signs order to speed up psychedelic review
Trump signs order to fast track psychedelic drug research to treat veterans with PTSD
Joe Rogan joins Trump to sign order allowing psychedelic drug research
Trump accelerates research on psychedelic treatments and asks, 'Can I have some?' - CNN
Trump signs order to hasten review of psychedelics
Fact ledger · what actually happened, cross-checked